Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction.
Principal Investigator (?)
Study Number
F17185
Summary
The purpose of this study is to determine if treatment with omecamtiv mecarbil/AMG 423 when added to standard of care is well tolerated and superior to placebo in reducing the risk of cardiovascular death or heart failure events in subjects with chronic HFrEF. 
Phase (?)
Phase III
Sponsor (?)
Contact

Gaylin Petty

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0